AI assistant
Sending…
Mirum Pharmaceuticals, Inc. — Director's Dealing 2023
Aug 28, 2023
31228_dirs_2023-08-28_447d9c1f-f62d-42b5-b0b4-b4c26ff1b19c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Mirum Pharmaceuticals, Inc. (MIRM)
CIK: 0001759425
Period of Report: 2023-08-25
Reporting Person: Howe Jolanda (SVP, Global Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-25 | Common Stock | S | 3459 | $26.2339 | Disposed | 0 | Direct |
More from Mirum Pharmaceuticals, Inc.
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 27
Annual Report
2026
Apr 24
Regulatory Filings
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18